VikramJoshuaPremkumarMDMS

Hematologic Oncology

Director of Hematologic Oncology, Holy Name Medical Center

Dr. Premkumar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
718 Teaneck Rd
Teaneck, NJ 07666
Phone+1 201-227-6008

Fax+1 201-530-7981

New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2017 - 2020
Tulane UniversityResidency, Internal Medicine, 2014 - 2017
Duke University HospitalPost-Doctoral Fellowship, 2013 - 2014
Tulane University School of MedicineClass of 2013, M.D.
Tulane University School of Medicine, Hayward Genetics CenterM.S., Biological Sciences; Concentration: Human Genetics, 2008 - 2009
Cornell UniversityB.A., Mathematics, 2004 - 2008

American Society of Hematology Abstract Achievement Award American Society of Hematology, 2013
Arnold P. Gold Foundation Help for Haiti Student Fellowship Grant Arnold P. Gold Foundation, 2010
Abstract Achievement Award American Society of Hematology, 2013

PubMed

7 citations
Antagonists of the system L neutral amino acid transporter (LAT) promote endothelial adhesivity of human red blood cells
Laura Beth Mann Dosier, BA Vikram J. Premkumar, Hongmei Zhu, Izzet Akosman, Michael F. Wempe
Thrombosis and Haemostasis. 2017-04-06
11 citations
Use of daratumumab in high risk multiple myeloma: A meta-analysis.
Vikram Premkumar, Samuel Pan, Suzanne Lentzsch, Divaya Bhutani
Ejhaem. 2020-07-01
51 citations
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis
Vikram J. Premkumar, Suzanne Lentzsch, Samuel Pan, Divaya Bhutani, Joshua Richter
Blood Cancer Journal. 2021-01-11

Journal Articles

Venetoclax in AL Amyloidosis- is this the beginning or the end?
Premkumar, V., Comenzo, R., Lentzsch, S, Clinical Lymphoma, Myeloma and Leukemia, 2019
Antagonists of the System L Neutral Amino Acid Transporter (LAT) Promote Endothelial Adhesivity of Human Red Blood Cells
Dosier, L, Premkumar, V, Zhu, H, et al., Thrombosis and Haemostasis, 2017
A Rare Presentation and Challenging Reconstruction of an Extensive Cystic Orbital Schwannoma
Ho, S., Premkumar, V, Valenzuela, A, Palacios, E, Vision Pan-America- The Pan-American Journal of Ophthalmology, 2013
Evaluation of the Electrocardiographic Criteria for Left Ventricular Hypertrophy with Use of Three-Dimensional Echocardiography
Gopal, A., Butkevich, A., Roychoudhury, D., Phillps, R., Echocardiography- A Journal of Cardiovascular Ultrasound and Allied Techniques, 1/1/2006
Join now to see all

Abstracts/Posters

Sequencing of Treatments in Metastatic CRPC for Patients Who Have Completed All Therapeutic Interventions.
Steinberger, A., Ledet, E., Feibus, A., Premkumar, V., Dotiwala, A., Stolten, M., Lewis, B., Sartor, AO., Genitourinary Cancers Symposium, San Francisco, CA, 1/1/2016
Listen to Your Brain But Follow Your Heart.
Premkumar, V., Davies, L., Hospital Medicine- Society of Hospital Medicine Annual Meeting; Society of General Internal Medicine Southern Regional Meeting, Atlanta, GA, 2016; San Diego, CA, 2016, 1/1/2016

Lectures

Single Arm, Prospective, Open-Label Phase II Trial to Evaluate the Efficacy of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019